FDA Bayesian Guidance Explained in New Video Presentation
New video presentation on the FDA Bayesian guidance: https://t.co/0wiz1JblkO #Statistics #Bayes #pharma #rct #clinicaltrials @fda @US_FDA
AI's Evolving Role in Statistics: Personal Insights
New presentation on my experiences and thoughts about the roles for AI in #Statistics: https://t.co/My5QUzAkxI #LLM #ai
One-Day Online Intro to R & RMS Workflow
1-day online course May 11: Intro to R/RStudio & an efficient comprehensive R workflow, rms package, enhancing regression skills to be ready for the RMS 4-day course. Details®istration at https://t.co/4IRUmtvm3H @AmstatNews @InstatsS #Statistics #rstats @VUDataScience
Key Overlooked Factors in Clinical Trial Design
New presentation on things we often forget to consider when designing a clinical trial: https://t.co/BVlSCIHdLu #Statistics #clinicaltrials
One-Day Online Intro to R and RMS Workflow
1-day online course May 11: Intro to R/RStudio & an efficient comprehensive R workflow, rms package, enhancing regression skills to be ready for the RMS 4-day course. Details®istration at https://t.co/4IRUmtvm3H @AmstatNews @InstatsS #Statistics #rstats @VUDataScience
Unexpected Email Reveals Hidden World of Ghost Workers
Just got this email out of the blue. Didn't know ghost workers was a thing. https://t.co/zl7IrKQEw3
New FDA Draft Bayesian Guidance Discussed with Dr. Gibson
Thrilled to be interviewed by imminent cardiologist and clinical trialist Mike Gibson yesterday about the new draft Bayesian guidance at FDA: https://t.co/I3uNISITKQ #Statistics #bayes #pharma #clinicaltrials #rct @CMichaelGibson
P > 0.05 Means Inconclusive, Not Proof of No Effect
Correct interpretation of p > 0.05: The current sample size did not yield sufficient evidence to reject, at the incredibly arbitrary 0.05 level, the supposition that the treatment does nothing, assuming data model M (describe M ...) which forgot to...
Paper on Target Trial Emulation Overlooks Confounding by Indication
How is it that a paper that claims to show how to do target trial emulation does not address confounding by indication and its ramifications for data collection? https://t.co/dzGZZdpBoc #Statistics
Bayesian Designs Decide Faster than Frequentist Group Sequential Methods
Goal-Driven Flexible Bayesian Design presentation updated w/comparison of performance of frequentist group sequential designs: https://t.co/QCZ6DQrm07 . Frequentist approach takes far too long to make a decision by controlling something that is NOT an error prob. #Statistics #rct https://t.co/X2knbmzTuX